XTAC
Live / Applied — Fifth extension granted (statement of use) (as of 16 Dec 2025)
What this means for you
Not registered yet, but its 11 Feb 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97263308
- Mark type
- Stylized text
- Filed
- 11 Feb 2022
- Published for opposition
- 11 Apr 2023
- Attorney of record
- Brent R. Bellows
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of pharmaceuticals targeting diseases mediated by extracellular proteins
Owner
- Avilar Therapeutics, Inc., Waltham, MA, US
- Avilar Therapeutics, Inc., Waltham, MA, US
Prosecution history
- 16 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Dec 2025 — SOU EXTENSION 5 GRANTED
- 07 Dec 2025 — SOU EXTENSION 5 FILED
- 08 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Jun 2025 — SOU EXTENSION 4 GRANTED
- 04 Jun 2025 — SOU EXTENSION 4 FILED
- 04 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Feb 2025 — SOU EXTENSION 3 GRANTED
- 05 Dec 2024 — SOU EXTENSION 3 FILED
- 05 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 16 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 May 2024 — SOU EXTENSION 2 GRANTED
- 06 May 2024 — SOU EXTENSION 2 FILED